[HTML][HTML] Automated next-generation profiling of genomic alterations in human cancers
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood, KMR Gerding… - Nature …, 2022 - ideas.repec.org
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood… - Nature …, 2022 - ui.adsabs.harvard.edu
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood… - Nature …, 2022 - econpapers.repec.org
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers.
LA Keefer, JR White, DE Wood, KMR Gerding… - Nature …, 2022 - europepmc.org
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers.
LA Keefer, JR White, DE Wood… - Nature …, 2022 - search.ebscohost.com
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood… - Nature …, 2022 - pure.johnshopkins.edu
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
[HTML][HTML] Automated next-generation profiling of genomic alterations in human cancers
LA Keefer, JR White, DE Wood… - Nature …, 2022 - ncbi.nlm.nih.gov
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
Automated next-generation profiling of genomic alterations in human cancers.
LA Keefer, JR White, DE Wood, KMR Gerding… - Nature …, 2022 - europepmc.org
The lack of validated, distributed comprehensive genomic profiling assays for patients with
cancer inhibits access to precision oncology treatment. To address this, we describe elio …
cancer inhibits access to precision oncology treatment. To address this, we describe elio …